Results showed that semaglutide did not increase the risk of kidney disease progression in patients with type 2 diabetes, even those with pre-existing kidney disease
Kathleen Dungan, an endocrinologist in the Division of Endocrinology, Diabetes & Metabolism at The Ohio State University Wexner Medical Center, there are several potential benefits to using semaglutide
Hydration and electrolytes: why water alone is not enough This is one of the most misunderstood aspects of GLP-1 treatment
This is also where the maintenance question becomes important, because the duration of GLP-1 agonist therapy directly impacts long-term outcomes
Low stamina, sluggish metabolism, poor glucose response, pre-diabetes support, performance optimization SS-31 "The Mitochondrial Repairman" The deep kind of fatigue not just tired, but feeling chronically run down, mentally foggy, and depleted in a way that rest doesnt fully resolve